NOVAVAX INC Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVAVAX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NOVAVAX INC for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | D | 128.60 | 73 | 9,388 | 287 | 360 to 287 (-20.28 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 5.95 | 1,149 | 6,837 | 12,651 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 5.95 | 6,249 | 37,182 | 68,751 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 46.00 | 2,082 | 95,772 | 12,507 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 27.60 | 1,668 | 46,037 | 5,009 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 27.00 | 2,214 | 59,778 | 0 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 27.00 | 394 | 10,638 | 0 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 124.17 | 506 | 62,830 | 287 | 793 to 287 (-63.81 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Payment of Exercise | F | 116.24 | 584 | 67,884 | 793 | 1.4 K to 793 (-42.41 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | D | 116.24 | 59 | 6,858 | 1,377 | 1.4 K to 1.4 K (-4.11 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 5.95 | 1,149 | 6,837 | 1,436 | 287 to 1.4 K (+400.35 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 115.11 | 349 | 40,172 | 287 | 636 to 287 (-54.87 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 114.25 | 1,500 | 171,378 | 636 | 2.1 K to 636 (-70.22 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 113.29 | 3,500 | 396,511 | 2,136 | 5.6 K to 2.1 K (-62.10 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 112.19 | 4,194 | 470,525 | 5,636 | 9.8 K to 5.6 K (-42.67 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 111.19 | 4,164 | 463,003 | 9,830 | 14 K to 9.8 K (-29.76 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 110.25 | 3,700 | 407,934 | 13,994 | 17.7 K to 14 K (-20.91 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 5.95 | 6,249 | 37,182 | 17,694 | 11.4 K to 17.7 K (+54.60 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 46.00 | 2,082 | 95,772 | 11,445 | 9.4 K to 11.4 K (+22.24 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 27.60 | 1,668 | 46,037 | 9,363 | 7.7 K to 9.4 K (+21.68 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 27.00 | 2,214 | 59,778 | 7,695 | 5.5 K to 7.7 K (+40.39 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 27.00 | 394 | 10,638 | 5,481 | 5.1 K to 5.5 K (+7.75 %) |
Jan 05 2021 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Director | Option Exercise | M | 50.00 | 1,000 | 50,000 | 0 | |
Jan 05 2021 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Director | Buy | M | 50.00 | 1,000 | 50,000 | 28,500 | 27.5 K to 28.5 K (+3.64 %) |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 51.40 | 10,000 | 514,000 | 0 | |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 50.00 | 1,000 | 50,000 | 0 | |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 113.60 | 2,000 | 227,190 | 0 | 2 K to 0 (-100.00 %) |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 112.98 | 9,000 | 1,016,825 | 2,000 | 11 K to 2 K (-81.82 %) |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 51.40 | 10,000 | 514,000 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 50.00 | 1,000 | 50,000 | 1,000 | 0 to 1,000 |